Dare Bioscience DARE
NASDAQ DARE
$0.68 -0.01 (-1.26%)
As of: Oct 21, 2026 · 3:49 PM EDT

Dare Bioscience (DARE) Preferred Stock Liabilities (2013 - 2014)

Updated

Dare Bioscience's Preferred Stock Liabilities was $81.53 million in Q1 2014, unchanged from the prior quarter.

Analysis

Dare Bioscience (DARE) Preferred Stock Liabilities (2013 - 2014) Analysis & Trends

  • In earlier years, Preferred Stock Liabilities was $83.75 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Dare Bioscience 10.13 Mn -55.33 Mn -132,343.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 81.53 Mn
Dec 31, 2013 81.53 Mn
API Access

Dare Bioscience Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=DARE&period=max&api_key=YOUR_API_KEY